Antimicrobial Susceptibility Testing

Antimicrobial susceptibility testing of vancomycin-resistant Enterococcus.

Susceptibility Testing

Vancomycin-Resistant Enterococcus (VRE)

Antimicrobial Resistance and Nosocomial Infections

• Bacterial endocarditis

Pure culture.

N/A

Send cultures as growth on culture medium or in transport medium. Culture vessel should be leak-proof or sealed appropriately.

Shipping of specimens shall be done by a TDG certified individual in accordance with TDG regulations. For additional information regarding classification of specimens for the purposes of shipping, consult either Part 2 Appendix 3 of the TDG Regulations or section 3.6.2 of the IATA Dangerous Goods Regulations as applicable.

 

N/A

Completed Antimicrobial Resistance and Nosocomial Infections Requisition.

N/A

Susceptibility testing is performed at the discretion of the lab by Etest, disk diffusion, or broth microdilution. Results are interpreted according to breakpoints published by CLSI, FDA, or EuCAST.

8 calendar days.

1. CLSI. Performance Standards for Antimicrobial Susceptibility Testing, 33rd informational supplement, M100-S27. 2023. Wayne, PA: Clinical and Laboratory Standards Institute.
2. The European Committee on Antimicrobial Susceptibility Testing (EuCAST). Breakpoint tables for interpretation of MICs and zone diameters. Version 13, 2023. http//www.eucast.org

Pathogen Safety Data Sheets: Infectious Substances – Enterococcus faecalis and Enterococcus faecium

Vancomycin-resistant Enterococci (VRE)